Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Pantin

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 24, 2021
The impact of early versus late tocilizumab administration in patients with cytokine release syndrome secondary to immune effector cell therapyRachel Peaytt, Laura Beth Parsons, Darby Siler, et al.
Haematologica|November 16, 2016
Effect of high-dose plerixafor on CD34<sup>+</sup> cell mobilization in healthy stem cell donors: results of a randomized crossover trialJeremy Pantin, Enkhtsetseg Purev, Xin Tian, et al.
Cytotherapy|December 9, 2025
Cryopreserved organ donor bone marrow achieves robust engraftment and chimerism in mismatched allogeneic transplantationErik J Woods, Sagar Munjal, Muneer H Abidi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2014
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuriaJeremy Pantin, Xin Tian, Nancy Geller, et al.
American Journal of Hematology|July 2, 2013
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromesJeremy Pantin, Xin Tian, Avni A Shah, et al.
British Journal of Haematology|February 8, 2017
Allogeneic transplantation using CD34<sup>+</sup> selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemiaEnkhtsetseg Purev, Xin Tian, Georg Aue, et al.
Blood Advances|February 23, 2018
Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemiaTibor J Kovacsovics, Alice Mims, Mohamed E Salama, et al.
Blood Advances|October 17, 2024
Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy networkMinoo Battiwalla, Michael Tees, Ian Flinn, et al.
Blood|December 12, 2025
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trialEverett Meyer, Amandeep Salhotra, Arpita Gandhi, et al.
British Journal of Haematology|September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR studyCelalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 24, 2021
The impact of early versus late tocilizumab administration in patients with cytokine release syndrome secondary to immune effector cell therapyRachel Peaytt, Laura Beth Parsons, Darby Siler, et al.
Haematologica|November 16, 2016
Effect of high-dose plerixafor on CD34<sup>+</sup> cell mobilization in healthy stem cell donors: results of a randomized crossover trialJeremy Pantin, Enkhtsetseg Purev, Xin Tian, et al.
Cytotherapy|December 9, 2025
Cryopreserved organ donor bone marrow achieves robust engraftment and chimerism in mismatched allogeneic transplantationErik J Woods, Sagar Munjal, Muneer H Abidi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2014
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuriaJeremy Pantin, Xin Tian, Nancy Geller, et al.
American Journal of Hematology|July 2, 2013
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromesJeremy Pantin, Xin Tian, Avni A Shah, et al.
British Journal of Haematology|February 8, 2017
Allogeneic transplantation using CD34<sup>+</sup> selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemiaEnkhtsetseg Purev, Xin Tian, Georg Aue, et al.
Blood Advances|February 23, 2018
Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemiaTibor J Kovacsovics, Alice Mims, Mohamed E Salama, et al.
Blood Advances|October 17, 2024
Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy networkMinoo Battiwalla, Michael Tees, Ian Flinn, et al.
Blood|December 12, 2025
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trialEverett Meyer, Amandeep Salhotra, Arpita Gandhi, et al.
British Journal of Haematology|September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR studyCelalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
Pageof 2